Cargando…

Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer’s Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry

OBJECTIVE: To investigate the changes in the cortical thickness of the region of interest (ROI) and plasma Aβ40, Aβ42, and phosphorylated Tau (P-Tau) concentrations in patients with Alzheimer’s disease (AD) and amnestic mild cognitive impairment (aMCI) as the disease progressed with surface-based mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kaidi, Qu, Hang, Ma, Mingyi, Xia, Chenyu, Cai, Ming, Han, Fang, Zhang, Qing, Gu, Xinyi, Ma, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083065/ https://www.ncbi.nlm.nih.gov/pubmed/35547625 http://dx.doi.org/10.3389/fnagi.2022.816043

Ejemplares similares

Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy
por: Putcha, Deepti, et al.
Publicado: (2019)

Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease
por: He, Pan, et al.
Publicado: (2022)

Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer’s Disease
por: Bachmann, Tobias, et al.
Publicado: (2023)

New Treatment for Alzheimer's Disease, Kamikihito, Reverses Amyloid-β-Induced Progression of Tau Phosphorylation and Axonal Atrophy
por: Watari, Hidetoshi, et al.
Publicado: (2014)

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
por: Wu, Jianfeng, et al.
Publicado: (2021)

Exploring Verbal Fluency Strategies among Individuals with Normal Cognition, Amnestic and Non-Amnestic Mild Cognitive Impairment, and Alzheimer’s Disease
por: Bairami, Styliani, et al.
Publicado: (2023)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Hippocampal atrophy and verbal episodic memory performance in amnestic mild cognitive impairment and mild Alzheimer’s disease: A preliminary study
por: Marchiani, Nathalia Carollina Peruzza, et al.
Publicado: (2008)

Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment
por: Liang, Chih-Sung, et al.
Publicado: (2021)

Comparison of Amyloid Positivity Rate and Accumulation Pattern between Amnestic and Non-Amnestic Type Mild Cognitive Impairment
por: Lee, Sun Hyung, et al.
Publicado: (2020)

False Memory and Alzheimer's Disease Pathology in Patients with Amnestic Mild Cognitive Impairment: A Study with Amyloid PET
por: Choi, Eun-Ji, et al.
Publicado: (2021)

High Fall Risk Associated With Memory Deficit and Brain Lobes Atrophy Among Elderly With Amnestic Mild Cognitive Impairment and Mild Alzheimer’s Disease
por: Huang, Shuyun, et al.
Publicado: (2022)

Movements Execution in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
por: Camarda, Rosolino, et al.
Publicado: (2007)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
por: den Haan, Jurre, et al.
Publicado: (2018)

Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients
por: Tomadesso, Clémence, et al.
Publicado: (2018)

Famous Landmark Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
por: Sheardova, Katerina, et al.
Publicado: (2014)

Estimation of Tau and Phosphorylated Tau(181) in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
por: Shekhar, Shashank, et al.
Publicado: (2016)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease
por: Therriault, Joseph, et al.
Publicado: (2021)

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease
por: Rui, Wenjuan, et al.
Publicado: (2021)

Using Voxel-Based Morphometry to Examine the Relationship between Regional Brain Volumes and Memory Performance in Amnestic Mild Cognitive Impairment
por: Meyer, Patric, et al.
Publicado: (2013)

The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Microstructural White Matter Changes, Not Hippocampal Atrophy, Detect Early Amnestic Mild Cognitive Impairment
por: Zhuang, Lin, et al.
Publicado: (2013)

Gray Matter Atrophy in Amnestic Mild Cognitive Impairment: A Voxel-Based Meta-Analysis
por: Zhang, Jinhuan, et al.
Publicado: (2021)

Divergent brain regional atrophy and associated fiber disruption in amnestic and non-amnestic MCI
por: Du, Chao, et al.
Publicado: (2023)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
por: Kim, Hyung-Ji, et al.
Publicado: (2022)

Characteristics of Agraphia in Chinese Patients with Alzheimer's Disease and Amnestic Mild Cognitive Impairment
por: Zhou, Jiong, et al.
Publicado: (2016)

Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Feng, Feng, et al.
Publicado: (2018)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Mesiotemporal atrophy and hippocampal diffusivity distinguish amnestic from non‐amnestic vascular cognitive impairment
por: Hosseini, A. A., et al.
Publicado: (2017)

A Longitudinal Study of Atrophy in Amnestic Mild Cognitive Impairment and Normal Aging Revealed by Cortical Thickness
por: Yao, Zhijun, et al.
Publicado: (2012)

Computerized multi-domain cognitive training reduces brain atrophy in patients with amnestic mild cognitive impairment
por: Zhang, Haifeng, et al.
Publicado: (2019)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

The Human Brain Representation of Odor Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Dementia of Mild Degree
por: Kjelvik, Grete, et al.
Publicado: (2021)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Prediction of Conversion From Amnestic Mild Cognitive Impairment to Alzheimer's Disease Based on the Brain Structural Connectome
por: Sun, Yu, et al.
Publicado: (2019)

Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment
por: Chen, Ting-Bin, et al.
Publicado: (2019)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s disease
por: Frigerio, Irene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rn9javl41a6a8lmj0bsoo845ii